| Fund | Type | Gross assets | Min. |
|---|---|---|---|
| Propel Bio Partners, L.P. | Venture Capital | $31.6M | $1M |
| Propel Bio SPV 3, LLC | Other Private | $19.2M | — |
| Propel Bio SPV 2, LLC | Other Private | $2.5M | $1M |
| Name | Title | Ownership | Since |
|---|---|---|---|
| Leen Kawas Control | Managing General Partner | Over 75% | 2022 |
| Xue Hua Control | Chief Compliance Officer | Under 5% | 2024 |
Propel Bio Management, LLC reports $131.4 million in regulatory assets under management on its Form ADV.
Propel Bio Management, LLC manages 4 private funds with combined gross assets of $55.9 million.
Propel Bio Management, LLC reports 7 employees.
Propel Bio Management, LLC is based in Los Angeles, CA and has been SEC-registered since 2022.
Propel Bio Management, LLC is not required to publicly disclose fund returns. Form ADV filings include assets, ownership, and service providers, shown above.
| Address | 11620 Wilshire Blvd, Suite 350, Los Angeles, CA 90025 |
| Phone | 206 602 9246 |
| Office hours | 8:00 - 5:00 |
| SEC region | Los Angeles Regional Office (LARO) |
| Discloses disciplinary history | No |
| Discretionary | $131.4M |
| Non-discretionary | $0 |
| Total (RAUM) | $131.4M |